Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 19)
Amneal Pharmaceuticals Says Receives Approval For Generic TobraDex
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ("Amneal" or the "Company") today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration
Amneal’s Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer
The FDA has accepted for review Amneal Pharmaceuticals Inc’s (NYSE:AMRX) marketing application seeking approval for Bevacizumab, under Section 351(k) pathway of…
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell
• Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.
5 Drug Manufacturers—Specialty & Generic Stocks Moving In Tuesday’s After-Market Session
Gainers • Assertio Therapeutics, Inc. (NASDAQ:ASRT) stock moved upwards by 3.1% to $1.34 during Tuesday’s after-market session. …
29 Healthcare Stocks Moving In Tuesday’s After-Market Session
Gainers • Genprex, Inc. (NASDAQ:GNPX) stock surged 18.3% to $1.36 during Tuesday’s after-market session. • Cutera, Inc. (NASDAQ:CUTR)…